Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis

Mycoses

Volumn 54, Issue 6, 2011, Pages 514-522

  Horre R ^a,b   Marklein, G ^a   Siekmeier, R ^b   Reiffert, S M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Federal Institute for Drugs and Medical Devices   (Germany)

Author keywords

Cystic fibrosis; Exophiala; Isolation techniques; Pseudallescheria; Scedosporium

Indexed keywords

CHLORAMPHENICOL; ERYTHRITOL;

ARTICLE; ASCOMYCETES; ASPERGILLUS; CONTROLLED STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; EXOPHIALA; FUNGAL DETECTION; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN; HYPHOMYCETES; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIUM; SPUTUM ANALYSIS; UPPER RESPIRATORY TRACT; UPPER RESPIRATORY TRACT INFECTION;

CULTURE MEDIA; CYSTIC FIBROSIS; HUMANS; MICROBIOLOGICAL TECHNIQUES; MITOSPORIC FUNGI; MYCOSES; RESPIRATORY TRACT INFECTIONS;

ASPERGILLUS; BURKHOLDERIA CEPACIA; CANDIDA ALBICANS; EXOPHIALA; EXOPHIALA DERMATITIDIS; FUNGI; HYPHOMYCETES; PSEUDALLESCHERIA; PSEUDOMONAS AERUGINOSA; SCEDOSPORIUM;

EID: 80053950121     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01897.x     Document Type: Article

References (47)

1. Cimon B, Carrère J, Chazalette JP et al. Bronchopulmonary mycoses in cystic fibrosis. Results of a five-year longitudinal study. J Mycol Méd 2000; 10: 128-35. In French.
2. Cimon B, Carrere J, Vinatier JF et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53-56.
3. Nagano Y, Millar BC, Johnson E et al. Fungal infections in patients with cystic fibrosis. Rev Med Microbiol 2007; 18: 11-16.
4. Kusenbach G, Skopnik H, Haase G, Friedrichs F, Dohmen H. Exophiala dermatitidis pneumonia in cystic fibrosis. Eur J Pediatr 1992; 151: 344-6.
5. Blaschke-Hellmessen R, Lauterbach I, Paul KD, Tintelnot K, Weissbach G. Detection of Exophiala dermatitidis (Kano) De Hoog 1977 in septicemia of a child with acute lymphatic leukemia and in patients with cystic fibrosis. Mycoses 1994; 37(Suppl. 1): 89-96. In German.
6. Horré R, de Hoog GS. Primary cerebral infections by melanized fungi: a review. Stud Mycol 1999; 43: 176-93.
7. Pihet M, Carrere J, Cimon B et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review. Med Mycol 2009; 47: 387-97.
8. Haase G, Skopnik H, Kusenbach G. Exophiala dermatitidis infection in cystic fibrosis. Lancet 1990; 336: 188-9.
9. Chabasse D, Bouchara JP, Chazalette JP et al. Cystic fibrosis and fungal colonization by Scedosporium apiospermum. About three cases. J Mycol Méd 1991; 1: 152-5. In French.
10. Williamson EC, Speers D, Arthur IH et al. Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease. J Clin Microbiol 2001; 39: 47-50.
11. Rainer J, Mayr A, Lass-Flörl C, Dierich MP. Abundance of P. Boydii in CF Patients, Detected With a Semi-Selective Isolation Method. Presented at the 2nd Meeting ECMM/ISHAM Working Group on Pseudallescheria/Scedosporium infections, Angers (France), 7-8 June, 2007.
12. Manno G. Isolation procedure, species identification and clinical significance of Aspergillus spp., Scedosporium spp., and other filamentous fungi in cystic fibrosis. Abstracts of the 13th Italian Cystic Fibrosis Conference. J Cystic Fibrosis 2008; 7: S3.
13. Symoens F, Knoop C, Schrooyen M et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25: 603-7.
14. Sahi H, Avery RK, Minai OA et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007; 26: 350-6.
15. Shah SS, Karnak D, Budev M, Avery RK, Mehta AC. Endobronchial Pseudallescheria boydii in lung transplant patient with cystic fibrosis. Bronchoscopic images. J Bronchology 2007; 14: 48-50.
16. Pinto MR, de Sá AC, Limongi CL et al. Involvement of peptidorhamnomannan in the interaction of Pseudallescheria boydii and HEp2 cells. Microbes Infect 2004; 6: 1259-67.
17. Da Silva BA, dos Santos AL, Barreto-Bergter E, Pinto MR. Extracellular peptidase in the fungal pathogen Pseudallescheria boydii. Curr Microbiol 2006; 53: 18-22.
18. Da Silva BA, Pinto MR, Soares RM, Barreto-Bergter E, Santos AL. Pseudallescheria boydii releases metallopeptidases capable of cleaving several proteinaceous compounds. Res Microbiol 2006; 157: 425-32.
19. Larcher G, Cimon B, Symoens F et al. A 33kDa serine proteinase from Scedosporium apiospermum. Biochem J 1996; 315: 119-26.
20. Gilgado F, Serena C, Cano J, Gené J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006; 50: 4211-3.
21. Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43: 4930-42.
22. Gilgado F, Cano J, Gené J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008; 46: 766-71.
23. Malloch D, Salkin IF. A new species of Scedosporium associated with osteomyelitis in humans. Mycotaxon 1984; 21: 247-55.
24. Tintelnot K, Haas A, Kaben U et al. A review of German Scedosporium prolificans cases from 1993 to 2007. Med Mycol 2009; 47: 351-8.
25. Rodriguez-Tudela JL, Berenguer J, Guarro J et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2009; 47: 359-70.
26. Lagrou K, Huysmans G, Verbeken E, Dupont L. Non-Aspergillus Filamentous Fungi in Cystic Fibrosis Patients. Presented at the Congress of the Netherlands Society for Medical Mycology/Paul Ehrlich Gesellschaft, Nijmegen. 21 November, 2006.
27. De Hoog GS, Haase G. Nutritional physiology and selective isolation of Exophiala dermatitidis. Antonie Van Leeuwenhoek 1993; 64: 17-26.
28. Rainer J, Kaltseis J, de Hoog GS, Summerbell RC. Efficacy of a selective isolation procedure for species of the Pseudallescheria boydii complex. Antonie Van Leeuwenhoek 2008; 93: 315-22.
29. Summerbell RC. The benomyl test as a fundamental diagnostic method for medical mycology. J Clin Microbiol 1993; 31: 572-7.
30. De Hoog GS, Guarro J, Gené J, Figueras MJ (eds). Atlas of Clinical Fungi, 2nd edn. Utrecht/Reus: Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, 2000.
31. Muthig M, Hebestreit A, Ziegler U, Seidler M, Muller FM. Persistence of Candida species in the respiratory tract of cystic fibrosis patients. Med Mycol 2010; 48: 56-63.
32. Blaschke-Hellmessen R, Paul KD, Ulbrich K, Jentsch Y. Exophiala dermatitidis bei Mukoviszidose. Diagnostik, Klinische Bedeutung und Therapie. Abstract of the 29th Annual Meeting of the German-speaking Mycological Society (D-MykG), Dresden. September, 1997; p. 108. In German.
33. Mouton JW, Brimicombe R, Weel J, Meis JFG, De Hoog GS. Exophiala Dermatitidis in Patients With Cystic Fibrosis: A Survey in the Netherlands. Topic Index - 20th EWGCF, June 1995. Brussels: European Cystic Fibrosis Society (ECFS). M033. URL [accessed on 24 April 2010].
34. Haase G, Skopnik H, Groten T, Kusenbach G, Posselt HG. Long-term fungal cultures from sputum of patients with cystic fibrosis. Mycoses 1991; 34: 373-6.
35. Rath PM, Müller KD, Dermoumi H, Ansorg R. A comparison of methods of phenotypic and genotypic fingerprinting of Exophiala dermatitidis isolated from sputum samples of patients with cystic fibrosis. J Med Microbiol 1997; 46: 757-62.
36. Diemert D, Kunimoto D, Sand C, Rennie R. Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis. Scand J Infect Dis 2001; 33: 777-9.
37. Gigi J, Lebecque P, Reychler G, Symoens F. Exophiala Dermatitidis: Airway Colonisation of the Upper Respiratory Tract in Belgian Cystic Fibrosis Patients. Presented at the Annual Congress of the Belgium Society of Mycology, Brussels, 12 April, 2008.
38. Nagano Y, Elborn JS, Millar BC, Goldsmith CE, Rendall J, Moore JE. Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF). J Cyst Fibros 2008; 7: 576-80.
39. Delhaes L, Harun A, Chen SC et al. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis 2008; 14: 282-90.
40. Tintelnot K, Wagner N, Seibold M, de Hoog GS, Horré R. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning. Mycoses 2008; 51(Suppl. 3): 11-16.
41. Robert Koch-Institute. Pseudallescheria-/Scedosporium-Arten. Bedeutung als opportunistische Erreger tiefer Schimmelpilz-Mykosen. Epidemiol Bull 2008; 29: 227-9. In German.
42. Garcia E, Rodriguez V, Gartner S, Gené J. Isolation of Scedosporium prolificans in patients with cystic fibrosis. Enferm Infecc Microbiol Clin 1998; 16: 488-9. In Spanish
43. Del Palacio A, Garau M, Amor E et al. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses 2001; 44: 321-5.
44. Lopez L, Gaztelurrutia L, Cuenca-Estrella M et al. Infection and colonization by Scedosporium prolificans. Enferm Infecc Microbiol Clin 2001; 19: 308-13. In Spanish.
45. Vagefi MR, Kim ET, Alvarado RG et al. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol 2005; 139: 370-3.
46. Nagano Y, Millar BC, Goldsmith CE et al. Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF). J Cyst Fibros 2008; 7: 566-72.
47. Whittaker LA, Teneback C. Atypical mycobacterial and fungal infections in cystic fibrosis. Semin Respir Crit Care Med 2009; 30: 539-46.